정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1752 | Not yet recruiting | Cromolyn Sodium for Treatment of COVID-19 Pneumonia | Pneumonia, Viral | Drug: Cromolyn Sodium Other: Placebo |
Phase 3 | Texas Tech University Health Sciences Center, El Paso | OTHER | 60 | All | 18 Years ~ 80 Years | University Medical Center of El Paso, El Paso, Texas, United States |
| 1751 | Active, not recruiting | CROWN CORONATION: COVID-19 Research Outcomes Worldwide Network for CORONAvirus prevenTION | COVID 19 | Drug: MR or M-M-R II ® vaccine Drug: Placebo |
Phase 3 | Washington University School of Medicine, COVID -19 Therapeutics Accelerator | OTHER | 3545 | All | 18 Years | Washington University School of Medicine, Saint Louis, Missouri, United States University of Ghana Medical Centre, Accra, Greater Accra Region, Ghana Groote Schuur/J52, Desmond Tutu Health Foundation, Mowbray, Cape Town, South Africa Masiphumelele, Desmond Tutu Health Foundation, Sunnydale, Cape Town, South Africa JOSHA Research, Bloemfontein, Free State, South Africa Wits RHI, University of the Witwatersrand, Hillbrow, Johannesburg,Gauteng, South Africa Clinical HIV Research Unit (CHRU), Auckland Park, Johannesburg, South Africa Perinatal HIV Research Unit (PHRU), Diepkloof, Johannesburg, South Africa Setshaba Research Centre, Soshanguve, Tshwane, South Africa Groote Schuur Hospital, Cape Town, Western Cape, South Africa FAMCRU (Family Clinical Research with Ubuntu), Cape Town, South Africa Chatsworth, HIV Prevention Research Unit, South African Medical Research Council, Chatsworth, South Africa Isipingo, HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa Aurum Institute Tembisa, Tembisa, South Africa University College London, London, United Kingdom Levy Mwanawasa University Teaching Hospital, Lusaka, Zambia Centre for Infectious Disease Research in Zambia [CIDRZ], Lusaka, Zambia |
| 1750 | Withdrawn | CSL324 in COVID-19 | Coronavirus Disease 2019 (COVID-19) | Biological: CSL324 Drug: Placebo |
Phase 2 | CSL Behring | INDUSTRY | 0 | All | 18 Years | |
| 1749 | Recruiting | Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 | ARDS, Human | Drug: poractant alfa | Phase 2 | Dr Christophe LENCLUD | OTHER | 20 | All | 18 Years ~ 100 Years | CH Francois Quesnay, Mantes la Jolie, France |
| 1748 | Not yet recruiting | Cyclosporine A Plus Low-steroid Treatment in COVID-19 Pneumonia | COVID 19 Pneumonia | Drug: Cyclosporin A | Phase 2 | Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado | OTHER_GOV | 200 | All | 18 Years | Jose Luis Jl Galvez-Romero, Puebla, Mexico |
| 1747 | Recruiting | Cyclosporine For The Treatment Of COVID-19(+) | SARS (Disease) | Drug: Cyclosporine Other: Standard of Care Treatment |
Phase 2 | Bryan Burt, MD, Brigham and Women's Hospital | OTHER | 75 | All | 18 Years ~ 90 Years | Baylor College of Medicine, Houston, Texas, United States |
| 1746 | Active, not recruiting | Cyclosporine in Patients With Moderate COVID-19 | COVID-19 | Drug: Cyclosporine | Phase 1 | University of Pennsylvania | OTHER | 20 | All | 18 Years | University of Pennsylvania, Philadelphia, Pennsylvania, United States |